Balance Sheet Details (Tables)

12 Months Ended

Dec. 31, 2021

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):

	December 31, 2021		December 31, 2020
Prepaid contract manufacturing expenses	$	3,808	$	121
Prepaid clinical trial expenses		1,397		998
Prepaid research and development expenses		627		775
Other prepaid expenses		1,218		275
Total	$	7,050	$	2,169

Schedule of Equipment, Net

Equipment, net, consist of the following (in thousands):

	December 31, 2021			December 31, 2020
Laboratory equipment	$	1,830		$	572
Office equipment and furniture		24			24
		1,854			596
Less accumulated depreciation		(407	)		(149	)
Total	$	1,447		$	447

Schedule of Accrued Compensation

Accrued compensation consist of the following (in thousands).

	December 31, 2021		December 31, 2020
Accrued salaries and payroll taxes	$	64	$	402
Accrued vacation		—		102
Accrued employee stock purchase plan contributions		129		—
Accrued bonuses		5,024		1,556
Accrued severance		161		662
Total	$	5,378	$	2,722

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	December 31, 2021		December 31, 2020
Accrued research and development expenses	$	2,123	$	216
Accrued clinical trial expenses		1,999		109
Accrued contract manufacturing expenses		906		1,343
Accrued legal expenses		531		490
Unvested early exercise liability		35		67
Accrued other		456		669
Total	$	6,050	$	2,894